Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
21.27
-0.71 (-3.23%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Castle Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 119.71 | 98.84 | 122.95 | 329.63 | 409.85 | Upgrade
|
| Short-Term Investments | 173.42 | 144.26 | 135.68 | - | - | Upgrade
|
| Cash & Short-Term Investments | 293.13 | 243.1 | 258.63 | 329.63 | 409.85 | Upgrade
|
| Cash Growth | 20.58% | -6.00% | -21.54% | -19.57% | 314.64% | Upgrade
|
| Receivables | 51.22 | 38.3 | 23.48 | 17.28 | 12.76 | Upgrade
|
| Inventory | 8.14 | 7.94 | 3.98 | 2.02 | 2.22 | Upgrade
|
| Prepaid Expenses | 7.67 | 6.29 | 6.21 | 4.81 | 4.77 | Upgrade
|
| Total Current Assets | 360.15 | 295.64 | 292.29 | 353.74 | 429.59 | Upgrade
|
| Property, Plant & Equipment | 62.71 | 37.74 | 26.5 | 16.88 | 7.1 | Upgrade
|
| Goodwill | 10.69 | 10.69 | 10.69 | - | - | Upgrade
|
| Other Intangible Assets | 95.54 | 106.64 | 115.66 | 88.92 | - | Upgrade
|
| Other Long-Term Assets | 2.15 | 2.63 | 2.2 | 3.02 | 2.63 | Upgrade
|
| Total Assets | 531.24 | 453.34 | 447.33 | 462.57 | 439.33 | Upgrade
|
| Accounts Payable | 6.9 | 10.27 | 4.73 | 2.55 | 2.1 | Upgrade
|
| Accrued Expenses | 38.7 | 35.26 | 29.21 | 20.5 | 11.81 | Upgrade
|
| Current Portion of Long-Term Debt | 0.28 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.77 | 1.21 | 1.93 | 1.28 | - | Upgrade
|
| Current Income Taxes Payable | 1.08 | 0.4 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.67 | 0.54 | 0.27 | 0.56 | 6.97 | Upgrade
|
| Total Current Liabilities | 49.39 | 47.67 | 36.13 | 24.89 | 20.88 | Upgrade
|
| Long-Term Debt | 9.75 | - | - | - | - | Upgrade
|
| Long-Term Leases | 14.66 | 14.2 | 11.62 | 7.02 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.61 | 0.21 | 0.43 | 0.64 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 18.29 | 2.76 | Upgrade
|
| Total Liabilities | 75.4 | 62.07 | 48.18 | 50.83 | 23.64 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 655.7 | 609.48 | 560.41 | 505.48 | 478.16 | Upgrade
|
| Retained Earnings | -200.13 | -218.37 | -160.91 | -93.77 | -62.5 | Upgrade
|
| Comprehensive Income & Other | 0.23 | 0.14 | -0.38 | - | - | Upgrade
|
| Total Common Equity | 455.84 | 391.27 | 399.15 | 411.74 | 415.69 | Upgrade
|
| Shareholders' Equity | 455.84 | 391.27 | 399.15 | 411.74 | 415.69 | Upgrade
|
| Total Liabilities & Equity | 531.24 | 453.34 | 447.33 | 462.57 | 439.33 | Upgrade
|
| Total Debt | 26.45 | 15.41 | 13.55 | 8.31 | - | Upgrade
|
| Net Cash (Debt) | 266.69 | 227.69 | 245.08 | 321.33 | 409.85 | Upgrade
|
| Net Cash Growth | 17.13% | -7.09% | -23.73% | -21.60% | 455.94% | Upgrade
|
| Net Cash Per Share | 9.12 | 8.50 | 9.41 | 12.78 | 21.65 | Upgrade
|
| Filing Date Shares Outstanding | 28.51 | 27.45 | 26.58 | 25.41 | 24.98 | Upgrade
|
| Total Common Shares Outstanding | 28.48 | 27.41 | 26.55 | 25.38 | 24.81 | Upgrade
|
| Working Capital | 310.76 | 247.97 | 256.16 | 328.86 | 408.72 | Upgrade
|
| Book Value Per Share | 16.00 | 14.27 | 15.03 | 16.22 | 16.75 | Upgrade
|
| Tangible Book Value | 349.61 | 273.93 | 272.8 | 322.82 | 415.69 | Upgrade
|
| Tangible Book Value Per Share | 12.27 | 9.99 | 10.27 | 12.72 | 16.75 | Upgrade
|
| Land | 7.25 | - | - | - | - | Upgrade
|
| Machinery | 32.48 | 22.92 | 15.35 | 7.47 | 3.78 | Upgrade
|
| Construction In Progress | 9.61 | 0.64 | 1.28 | 0.03 | 3.59 | Upgrade
|
| Leasehold Improvements | 14.62 | 9.99 | 5.17 | 5.04 | 1.39 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.